Skip to main content
. 2017 Oct 16;17(2):524–530. doi: 10.1177/1534735417734914

Table 1.

Patient Characteristics at Baseline.

GGBT Group Wait-List Group P a
Age, median (range) 55.7 (23.0-70.0) 52.6 (38.0-73.0) .407
Men, n (%) 8 (53.5) 6 (40.0) .481
BMI, kg/m2, mean (SD) 23.1 (3.2) 23.3 (3.7) .855
Primary Tumor, n (%) .751
 Breast 5 (33.3) 3 (20.0)
 Lung 2 (13.3) 1 (6.7)
 Gastrointestinal 6 (40.0) 7 (46.7)
 Other 2 (13.3) 4 (26.7)
TNM Stage, n (%) .218
 I 4 (26.7) 2 (13.3)
 II 2 (13.3) 0 (0.0)
 III 2 (13.3) 6 (40.0)
 IV 7 (46.7) 7 (46.7)
Concurrent treatments, n (%)
 Chemotherapy 5 (33.3) 3 (20.0) .426
 Radiotherapy 2 (13.3) 1 (6.7) .559
 Hormonal therapy 3 (20.0) 3 (20.0) .999
 Hypnotics 2 (13.3) 4 (26.7) .379
PSQI Score, mean (SD) 14.1 (2.8) 14.5 (2.6) .640
ECOG PS, n (%) .359
 0 3 (20.0) 4 (26.7)
 1 10 (66.7) 11 (73.3)
 ≥2 2 (13.3) 0 (0.0)

Abbreviations: GGBT, Gamiguibi-tang; BMI, body mass index; PSQI, Pittsburgh Sleep Quality Index; ECOG PS, Eastern Cooperative Oncology Group performance status.

a

P value was calculated using the independent t test, chi-square test, or Fisher’s exact test.